What happened to the variants that once wreaked havoc? “For all intents and purposes, we can consider them gone,” said David Dowdy, an epidemiology professor at Johns Hopkins Bloomberg School of Public Health.
Analysis of a subgroup of patients hospitalized primarily for COVID-19 or flu found that the risk of death was 2.5 times higher, and the likelihood of ICU admission was 1.7 times higher, among Omicron than flu patients.
Long-COVID patients have higher rates of unemployment and underemployment than their recovered peers and are likely to have persistent or new-onset symptoms, disabilities, and financial problems in the 6 months after hospitalization, according to two US studies published in JAMA Network Open. ...
Two new studies, one from the United States and one from Canada, suggest that the oral antiviral drug Paxlovid (nirmatrelvir-ritonavir) is effective in lowering the odds of hospitalization or death from the SARS-CoV-2 Omicron subvariant.
Recent Comments